BATS | ETF
The fund is an actively-managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution (Genomics Revolution Companies).
It is non-diversified.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
TEM | Tempus AI, Inc. Class A Common Stock | Healthcare | Health Information Services | 11.11% |
CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 9.86% |
TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 5.26% |
RXRX | Recursion Pharmaceuticals Inc | Healthcare | Biotechnology | 4.95% |
NTLA | Intellia Therapeutics Inc | Healthcare | Biotechnology | 4.70% |
PSNL | Personalis Inc | Healthcare | Diagnostics & Research | 4.56% |
GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 4.05% |
BEAM | Beam Therapeutics Inc | Healthcare | Biotechnology | 4.01% |
NTRA | Natera Inc | Healthcare | Diagnostics & Research | 3.81% |
IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 3.48% |
ADPT | Adaptive Biotechnologies Corp | Healthcare | Biotechnology | 3.46% |
ABSI | Absci Corp | Healthcare | Biotechnology | 3.43% |
VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 3.29% |
SDGR | Schrodinger Inc | Healthcare | Health Information Services | 3.20% |
ARCT | Arcturus Therapeutics Holdings Inc | Healthcare | Biotechnology | 3.15% |
TXG | 10X Genomics Inc | Healthcare | Health Information Services | 3.10% |
ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 2.89% |
CDNA | CareDx Inc | Healthcare | Diagnostics & Research | 2.59% |
PRME | Prime Medicine, Inc. Common Stock | Healthcare | Biotechnology | 2.39% |
MASS | 908 Devices Inc | Healthcare | Medical Devices | 1.36% |